Clinic
ST. David's Healthcare Partnership, L.P., LLP
ST. David's Healthcare Partnership, L.P., LLP was paid $7.06M by Medicaid between Nov 2020 and Dec 2024, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
33Billing provider infoST. DAVID'S HEALTHCARE PARTNERSHIP, L.P., LLP
AUSTIN, TX 78704
AUSTIN, TX 78704
33aNPI1679528889assigned 05/24/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$7.06M
24GClaims93,209
24DCodes billed53
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#64 of 320
Median peer was paid$205K
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,217 | $113K | |
| 2021 | 23,304 | $1.68M | |
| 2022 | 29,687 | $2.29M | |
| 2023 | 29,000 | $2.35M | |
| 2024incomplete | 10,001 | $636K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 24,335 | 23,717 | $3.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 45% | 10,617 | 10,183 | $3.19M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 1,871 | 1,841 | $249K |
| 80053 | Comprehensive metabolic panel | <1% | 7,855 | 7,321 | $54K |
| 85027 | <1% | 13,535 | 12,561 | $45K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,271 | 2,226 | $43K |
| 87400 | <1% | 3,075 | 2,984 | $43K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 262 | 79 | $35K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,003 | 2,848 | $28K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,511 | 1,489 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,980 | 1,836 | $20K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 134 | 131 | $18K |
41 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 2,067 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 507 | $16K |
| 59025 | Fetal non-stress test | <1% | 99 | $14K |
| 99285 | Emergency room visit (most serious) | <1% | 290 | $13K |
| 81001 | <1% | 6,879 | $12K | |
| 87430 | <1% | 621 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 67 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,343 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,046 | $4K |
| 83690 | <1% | 1,465 | $3K | |
| 76801 | <1% | 31 | $3K | |
| 84484 | <1% | 1,413 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $1K |
| 84703 | <1% | 310 | $961.04 | |
| 83880 | <1% | 186 | $832.00 | |
| 84702 | <1% | 53 | $658.38 | |
| 80306 | <1% | 85 | $544.00 | |
| 81025 | <1% | 110 | $449.91 | |
| 82077 | <1% | 168 | $434.61 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 276 | $332.52 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 754 | $268.17 |
| 83735 | <1% | 124 | $221.53 | |
| 86901 | <1% | 160 | $210.84 | |
| 86900 | <1% | 160 | $210.84 | |
| 85610 | <1% | 404 | $140.27 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 180 | $137.66 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 235 | $122.12 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 123 | $114.03 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 58 | $110.25 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 209 | $99.37 |
| 85730 | <1% | 114 | $60.89 | |
| 87807 | <1% | 21 | $53.72 | |
| 87040 | <1% | 20 | $34.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 58 | $22.04 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 42 | $15.21 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 15 | $1.46 |
| A9270 | Non-covered item or service | 0% | 2,631 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 53 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 28 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 16 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 327 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, BRYAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Kph-Consolidation, INC. | Kingwood, TX | $36.51M |
| Bryan X Lee MD a Professional Medical Corporation | Pomona, CA | $2.19M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.